Loading...
Odonate Therapeutics, Inc.
ODTC•PNK
Healthcare
Biotechnology
$22005.00
$5005.00(29.44%)
Odonate Therapeutics, Inc. (ODTC) Company Profile & Overview
Explore Odonate Therapeutics, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
Odonate Therapeutics, Inc. (ODTC) Company Profile & Overview
Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was founded in 2013 and is based in New York, New York.
SectorHealthcare
IndustryBiotechnology
CEOKevin C. Tang
Contact Information
Company Facts
137 Employees
IPO DateDec 7, 2017
CountryUS